MedTrace Logo

Consent Forms in Cancer Research: Examining the Effect of Length on Readability

NCT04548063 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 266

Last updated 2024-08-29

No results posted yet for this study

Summary

Researchers are using mock consent forms to see if wordiness has any effect on patients' understanding and willingness to sign up for a cancer clinical trial.

Conditions

Interventions

OTHER

6,000 word consent form

Mock consent form with consistent content in approximately 6,000 word length.

OTHER

4,000 word consent form

Mock consent form with consistent content in approximately 4,000 word length.

OTHER

2,000 word consent form

Mock consent form with consistent content in approximately 2,000 word length.

Sponsors & Collaborators

Principal Investigators

  • Aminah Jatoi, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-08
Primary Completion
2020-11-06
Completion
2020-11-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04548063 on ClinicalTrials.gov